RE: Novacyt PR22 Dec 2020 08:52
Bakky at this rate there will only be you and Ash talking to each other.
I'm not sure why you feel the need to filter anyone with a negative opinion about this company. Admittedly some criticism might be overdone, but its not without foundation and it certainly would be nice read more positive comments, but they will only come when the company starts delivering.
Surely, anyone who has invested has the right to comment? You can debate all day about the rights and wrongs of what strategies individuals choose to 'invest' their money its their prerogative, but it doesn't mean that any negative comment about the company is always de-ramping. Why do it when we all have money tied up in it, or I least I'd like to think we have or else why visit this BB? I have picked up lots of useful information about YGEN since I first visited this BB (almost 1yr to the day) but I am like dozens of others on this board incredibly disappointed, frustrated and ****ed off.
I do think there a people on this BB who are not critical enough and should be, because as an investment and for what ever reason this stock in my opinion has not performed. Yes its been a truly exceptional year and disastrous for some investment sectors, but it HAS been the year for molecular diagnostics/ testing and yet we have still lost value? Yes the core business is still growing and establishing itself in new territories and COVID hasnt helped but thank goodness for the 'extra' Covid work and even that now seems disappointing. The lack of absolute detail from the company is particularly galling and I think this is what is turning my sentiment.
I am absolutely certain that Lyns main and only priority is to establish this company, in what is a hugely competitive market and he is doing this by organic growth and expanding into new territory, returning immediate share holder value is not an immediate priority. For these guys this is their modus operandi - establish/acquisitions.... bonuses move on. Its not a particularly visible stock from a PR perspective and there is not enough share movement to make it a day trading stock. This comes back investment strategy, do you believe in the company or not?
I have worked in Biotech/Pharma for 30yrs and its an area of investment that attracts me and my own personal area of interest is Translational Biology/biomarker design. I do think molecular diagnostics and personalised medicine are the future but I reiterate it is hugely competitive, niche and has still has to prove itself in many disease areas. Ideally you need a competitive technological advantage with solid IP. PCR design is trivial and to be honest any company could design primers to create molecular screening kit. IMO its how rapidly you promote and sell this that will determine success.